Smoking Cessation and Nicotine De-addiction Products Market, By Route of Administration, By Product, By Distribution Channel, By Geography

Description

The Global Smoking Cessation and Nicotine De-addiction Products Market is estimated to be valued at USD 16.55 Bn in 2024 and is expected to reach USD 50.10 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 17.1% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 16.55 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	17.10%	2031 Value Projection:	US$ 50.10 Bn

Figure. Smoking Cessation and Nicotine De-addiction Products Market Share (%), By Region 2024

Smoking Cessation and Nicotine De-addiction Products Market - IMG1

The global market for smoking cessation and nicotine de-addiction products is growing significantly owing to the rising global population of smokers and increasing awareness about health hazards of smoking. Smoking has become a worldwide public health issue and the World Health Organization (WHO) recommends various measures to help people quit tobacco consumption. Nicotine replacement therapies and other smoking cessation aids are proving effective in assisting smokers to break the habit. Several awareness campaigns by governments and NGOs have boosted the demand for nicotine gums, patches, lozenges and prescription medications for quitting smoking. Advancements in product formulations and newer technologies are expanding the choices available to smokers who want to quit. However, high prices of certain de-addiction products and persistence of tobacco addiction pose challenges to the industry.

Market Dynamics:

The global smoking cessation and nicotine de-addiction products market growth is driven by the increasing prevalence of smoking-related diseases, growing health consciousness among consumers, and various initiatives by public organizations to curb tobacco use. However, high costs of certain smoking cessation therapies, along with strong tobacco industry lobbying against product regulations, are restraining the market growth. The widespread adoption of digital solutions for smoking cessation therapies is opening new opportunities. Various mobile apps and online programs are being developed to improve the effectiveness of nicotine replacement therapies and behavioral support for consumers. Innovation in alternate delivery forms of nicotine is another key trend gaining traction.

Key Features of the Study:

This report provides in-depth analysis of the global smoking cessation and nicotine de-addiction products market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global smoking cessation and nicotine de-addiction products market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include GlaxoSmithKline, Pfizer, Johnson & Johnson, and Dr. Reddy's Laboratories
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global smoking cessation and nicotine de-addiction products market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global smoking cessation and nicotine de-addiction products market.

Detailed Segmentation-

By Route of Administration
- Oral
- Transdermal
- Nasal
- Sublingual
- Oral
By Product
- Nicotine Replacement Therapy
- Nicotine Spray
- Nicotine Inhalers
- Nicotine Gum
- Nicotine Transdermal Patches
- Nicotine Sublingual Tablets
- Nicotine Lozenges
- Drug Therapy
- Varenicline
- Zyban
- Nicorette Buccal
- E-cigarettes/E-liquid
By Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- GlaxoSmithKline plc (GSK)
- Pfizer Inc.
- Johnson & Johnson
- Novartis International AG
- Imperial Brands plc
- British American Tobacco plc (BAT)
- Cipla Inc.
- McNeil AB
- NJOY, Inc.
- Reddy's Laboratories Ltd.
- Perrigo Company plc
- Fertin Pharma
- Philip Morris International Inc.
- Alkalon A/S
- Japan Tobacco Inc.
- Nicotek, LLC
- 22nd Century Group Inc.

Product Code: CMI134

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Route of Administration
- Market Snapshot, By Product
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Smoking Cessation and Nicotine De-addiction Products Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Smoking Cessation and Nicotine De-addiction Products Market, By Route of Administration, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Transdermal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Nasal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Sublingual
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Smoking Cessation and Nicotine De-addiction Products Market, By Product, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Nicotine Replacement Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Nicotine Spray
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Nicotine Inhalers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Nicotine Gum
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Nicotine Transdermal Patches
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Nicotine Sublingual Tablets
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Nicotine Lozenges
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Drug Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Varenicline
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Zyban
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Nicorette Buccal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
E-cigarettes/E-liquid
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Smoking Cessation and Nicotine De-addiction Products Market, By Distribution Channel, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Hospital Pharmacy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Online Pharmacy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Retail Pharmacy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Smoking Cessation and Nicotine De-addiction Products Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
  - Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- GlaxoSmithKline plc (GSK)
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Pfizer Inc.
- Johnson & Johnson
- Novartis International AG
- Imperial Brands plc
- British American Tobacco plc (BAT)
- Cipla Inc.
- McNeil AB
- NJOY, Inc.
- Dr. Reddy's Laboratories Ltd.
- Perrigo Company plc
- Fertin Pharma
- Philip Morris International Inc.
- Alkalon A/S
- Japan Tobacco Inc.
- Nicotek, LLC
- 22nd Century Group Inc.

10. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

11. References and Research Methodology

References
Research Methodology
About us and Sales Contact